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The strong interest in cell death, and the shift in emphasis from basic mechanisms to translational aspects fostered the launch
last year of the new sister journal of Cell Death and Differentiation, named Cell Death and Disease, to reﬂect its stronger focus
towards clinical applications. Here, we review that ﬁrst year of activity, which reﬂects an enthusiastic response by the scientiﬁc
community. On the basis of this, we now launch two novel initiatives, the start of a new section dedicated to cancer metabolism
and the opening of a new editorial ofﬁce in Shanghai.
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It is impossible to overstate the relevance of cell death
research to human pathology. Compromised cell death
pathways clearly contribute to proliferative diseases, and
overactive death mechanisms are implicated in degenerative
disease. In addition, cell death results from ischaemic
episodes, and reducing ischaemic death correspondingly
reduces the structural and functional deﬁcits that follow, for
example, myocardial and cerebral infarction. It is also likely
that manipulation of the form of cell death that follows injuries
such as ischaemia may also inﬂuence disease outcome.
Thus, converting cell loss from a necrotic to an apoptotic
phenotype will reduce the associated inﬂammation, resulting
in a smaller ﬁnal lesion and fewer clinical consequences.
In 1991, a mouse strain was serendipitously discovered for
its resemblance to patients with the disease Systemic Lupus
Erythematosus, that is, the mice showed a tendency to
develop enlarged lymph nodes and spleens along with
autoimmune diseases such as immune complex glomerulo-
nephritis.
1 The mice, named lpr and gld, had mutations in
CD95 (Fas, Apo-1) and CD95L (FasL, Apo-1L), respectively.
The lymphocytes from these mice proliferated normally in
response to antigenic challenges, but they failed to be
eliminated at the end of the immune response because of
the mutation in the death receptor and its ligand (CD95 and
CD95L) that impaired the ability to undergo apoptosis,
resulting in an abnormal T-cell accumulation in the lymphoid
tissues. Some of the lymphocytic clones triggered autoim-
mune diseases. Furthermore, the normal development of
T cells was defective in these mice, with drastically reduced
doublepositive mature T cells,which should normally express
either CD4 or CD8 markers along with CD3 receptors for
antigen. This was the ﬁrst clear evidence of defects in the cell
death machinery leading to immunological disease, both in
mice and human. The molecular mechanisms regulating
the activation of death receptors have now been analysed
in detail, with their ubiquitylation
2–4 regulating cell fate.
5
In addition to elucidating the role of death receptors in
inﬂammation and immunity, the improved understanding of
these pathways opens novel therapeutic perspectives, which
are only now beginning to be exploited in the clinic.
Cell death is crucial also for the development of malignan-
cies. Here, the list of defective genes linked to the cell death
machinery is long and well established, see, for example, the
role of p53. This transcription factor regulates cell cycle as well
as cell death.
6 Humans with defects in p53 (Li–Fraumeni
syndrome) are cancer-prone. Loss of p53 function by gene
mutation or other mechanisms of inactivation has been shown
tobea characteristic ofa large majorityofhumantumours,and
many tumours also have lost genes whose products stabilize
p53, such as ataxia telangiectasia mutated.
7–9
DNAdamageisnormallydetectedinthenucleusbyspeciﬁc
protein complexes, which then can induce cell cycle arrest
and/orclassicapoptosisviap53,orviaitsfamilymembersp73
or p63,
10,11 (Figure 1) and deregulation of these pathways
leads to cancer progression. The stability of proteins of the
p53 family is regulated by speciﬁc ubiquitin E3 ligases
12 and,
correspondingly, inhibition of these E3 enzymes would
stabilize the protein with enhancement of its activity. Thus,
pharmacological methods for stabilizing the p53 family of
transcription factors would seem to offer a potential ther-
apeutic window (Figures 1b and c). Interestingly, in addition to
classic apoptosis, the p53 family members are able to interact
with components of the kinetochore complex such as
BubR1,
13,14 affecting mitosis and leading to mitotic cata-
strophe. Of course, the p53 family, like other transcription
factors, does not act in isolation at enhancer elements, but
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their transcriptional activity on speciﬁc targets. Unlike the
vast literature devoted to p53 and its siblings, however,
comparatively little attention has been focused on these
cofactors, and a better understanding of how speciﬁc
cofactors may act to enhance the apoptotic activity of p73 in
cancers where p53 is inactive may provide other therapeutic
opportunities.
Intrinsic cell death pathways exist in a state of dynamic
equilibrium between pro- and anti-apoptotic elements. Death
receptor signalling, for example, is inhibited by cFLIP, and
activation of procaspase-9 within the apoptosome is
restrained by X-IAP until Smac/DIABLO is released from
damaged mitochondria. This inherent balance provides an
opportunity for inﬂuencing death decisions both to enhance
and to reduce cell death. In addition to these intrinsic factors,
otherextrinsicintracellular factors,suchastheurocortins, can
also powerfully inﬂuence the outcome of cell death stimuli.
So far, we have concentrated on the manipulation of
apoptosis as a means of inﬂuencing pathology – what of
necrotic death? It remains unclear how much of the necrosis
that occurs, for example, in myocardial infarction, is a
catastrophic and irreversible event, and how much occurs
as programmed necrosis. The former would probably not be
possible to target therapeutically, but the latter mechanism,
once its molecular details are better understood, may provide
potential therapeutic windows. Finally, in the panoply of cell
death modalities, what is the contribution of autophagy to
death pathologies – is it protective, and should we therefore
promote it, or does it contribute to cell loss? Some evidence
suggeststhatitisthe severityandduration ofthestimulus that
determines this, and short stimuli, such as brief ischaemia,
result in an autophagic process, which is protective by
providing an intracellular source of nutrients. This, if not
resulting in cell salvage, may allow less harmful apoptotic
death to proceed instead of necrosis. Since we have hung up
our Gilsons much more recently than when we began to help
patients, we tend to compartmentalize cell death modes into
neat academic entities, but in the real world of patients with




p53 can be inhibited by speciﬁc low molecular compounds, currently in clinical trials, leading to restoration of p53 steady state protein levels and function. (c) Similarly, the
degradation of p63 and p73 is mainly regulated by the ubiquitin E3 ligase ITCH, which offers also a novel therapeutic target. ITCH, in mediating its activity, undergoes a
conformational modiﬁcation in the C-terminal portion (WWP1/AIP5 versus E6AP) in a speciﬁc hinge region
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Cell Death and Diseaseinteract. As such, effective therapies will need to address all
cell death subroutines.
Clearly, the study of cell death is pivotal to understand and
manipulate disease processes,
15,16 and this was the scientiﬁc
basis for launching last year a translational sister journal of
Cell Death and Differentiation (CDD).
Cell Death and Disease, CDDIS, was launched in January
2010 as the ﬁrst peer-reviewed open access online journal by
Nature Publishing Group that publishes full-length papers,
reviews and commentaries describing original research in the
ﬁeldoftranslationalcelldeath.Itseekstopromotediverseand
integrated areas of Experimental and Internal Medicine in
specialties such as cancer, immunity and neuroscience.
CDD is now in its eighteenth volume and, given the
conventional 20-year time lag for the journey from bench to
bedside, 2010 seemed an appropriate time to launch CDDIS.
This reﬂects the fact that the academic Cell Death ﬁeld has
now become mature enough to contribute to the physiology
and pathology ﬁeld, a fact reﬂected in the growing interest in
cell death by pharmacists and clinicians. Thus, a signiﬁcant
proportion of papers are focused on translational and
therapeutic aspects, and therefore CDDIS seeks to encom-
passthebreadthoftranslationalimplicationsofcelldeath,and
topics of particular concentration will include, but are not
limited to, the subspecialities highlighted above.
The original plan was to publish 30 papers in the ﬁrst year.
Instead the response by the scientiﬁc community was so
positive that CDDIS has published over 100 papers in its ﬁrst
year of life. More important, this success has encouraged
NPG to launch more new open access journals, and so now
we are witnessing the birth of a number of scientiﬁc journals,
all based on this novel experimental business model.
DatafromMedlineshowthatin2010,atotalof23611papers
have been published (compared with 5458 in 1995 or 2219 in
1990) in the area of cell death. By inputting the keywords ‘cell
death’ and ‘medicine’, the search yields 5990 (25.4%) papers,
while ‘cell death’ with ‘cancer’yields9306(39.4%) papers, with
‘neuron’ 2313 (9.8%) papers, with ‘heart’ 1238 (5.2%) papers
and with ‘immunity’ 1091 (4.6%) papers. See Table 1 for more
details. Inorder tocompare witha morebasic interest, the total
number of papers on ‘cell deathþcaspases’ reduced from




we are witnessing a shift in interest from basic molecular
mechanisms to the manipulation of cell death in pathology.
Table 2 shows that CDDIS has followed this translational
trend, publishing a signiﬁcant number of papers equally
distributed in the different sections.
How can we make CDDIS evolve in the right direction?




to 17284 (73.5%) papers. See also Table 1. More generally,
the number of scientiﬁc papers on ‘cancer metabolism’ has
increased from 16924 in 1995 to the respectable number of
44769 in 2010. For this reason, CDDIS has decided to
immediately launch a new section of CDDIS dedicated to
Cancer Metabolism. Christina Munoz-Pinedo will help us to
achieve this aim.
An interesting new trend in recent years is the rise of high
quality science in China and, indeed, several leading
scientists have moved back from the United States and
Europe to mainland China encouraged by the huge ﬁnancial
investment thathasbeen putin placeinChina.Accordingly, in
Table 1 Number of papers published in the ﬁeld of ‘Cell Death’
Year 1990 1995 2000 2005 2010
CD+cancer 593 1668 4161 6846 9306
CD+medicine 486 1197 3260 4897 5990
CD+neuron 221 684 1566 2108 2313
CD+heart 161 211 555 875 1238
CD+immunity 67 305 601 898 1091
CD+metabolism 690 2583 8157 13556 17394
CD 2219 5458 12513 18517 23611
Autophagy 29 29 70 261 1823
Abbreviation: CD, cell death Data from Medline/Pubmed















Nasopharyngeal carcinoma, mesothelioma 17,55,56
Leukaemia 57–60











Mast cells, macrophages 87,89
Internal medicine
Steatosis 90









Nitric oxide, NMDA 122,123
Hypoxia-ischaemia 36,90,124
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Cell Death and DiseaseMay of this year CDDIS organized a scientiﬁc meeting in
Shanghai in the presence of several members of the Editorial
board,including AndreasStrasser,Tak W Mak,MartinBushell,
XinLu,DougRGreen,YufangShiandbothofus.Toreﬂectthe
increase in high quality scientiﬁc output from China, and the
global inﬂuence this will have in the future, we are opening a
new Editorial Ofﬁce in Shanghai, headed by Yufang Shi.
We hope that these novel initiatives will help us to build on a
successful ﬁrst 18 months and to reach a wider international
audience. Our goal, as always, is to provide a satisfying and
stimulating forum of knowledge exchange, particularly for
those seeking to exploit basic cell death research in the clinic
as well as for those more interested in how cell death
modalities relate to disease rather than in the molecular
complexities of the pathways involved.
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